Mounjaro®
Mounjaro® is an FDA-approved brand-name tirzepatide originally indicated for type 2 diabetes, with dual GLP-1 and GIP receptor action that has shown significant weight loss results in clinical trials.
AI Readiness
Good foundation, but some important product data is still missing.
67%